Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 810

Similar articles for PubMed (Select 15338849)

1.

Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.

Hall LG, Oyen LJ, Taner CB, Cullinane DC, Baird TK, Cha SS, Sawyer MD.

Pharmacotherapy. 2004 Aug;24(8):1002-12.

PMID:
15338849
2.

Low-dose vasopressin in the treatment of vasodilatory septic shock.

Malay MB, Ashton RC Jr, Landry DW, Townsend RN.

J Trauma. 1999 Oct;47(4):699-703; discussion 703-5.

PMID:
10528604
3.

Vasopressin versus norepinephrine infusion in patients with septic shock.

Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D; VASST Investigators.

N Engl J Med. 2008 Feb 28;358(9):877-87. doi: 10.1056/NEJMoa067373.

4.

Changes in vasopressin use and outcomes in surgical intensive care unit patients with septic shock.

Lupei MI, Beilman GJ, Chipman JG, Mann HJ.

Chirurgia (Bucur). 2009 Sep-Oct;104(5):575-81.

PMID:
19943557
5.

Effects of continuous vasopressin infusion in patients with septic shock.

Obritsch MD, Jung R, Fish DN, MacLaren R.

Ann Pharmacother. 2004 Jul-Aug;38(7-8):1117-22. Epub 2004 Jun 3.

PMID:
15178740
6.

Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.

Micek ST, Shah P, Hollands JM, Shah RA, Shannon WD, Kollef MH.

Surg Infect (Larchmt). 2007 Apr;8(2):189-200.

PMID:
17437364
7.

Lack of an effect of body mass on the hemodynamic response to arginine vasopressin during septic shock.

Lam SW, Bauer SR, Cha SS, Oyen LJ.

Pharmacotherapy. 2008 May;28(5):591-9. doi: 10.1592/phco.28.5.591.

PMID:
18447658
8.

High-dose vasopressin is not superior to norepinephrine in septic shock.

Klinzing S, Simon M, Reinhart K, Bredle DL, Meier-Hellmann A.

Crit Care Med. 2003 Nov;31(11):2646-50.

PMID:
14605537
9.

Beneficial effects of short-term vasopressin infusion during severe septic shock.

Patel BM, Chittock DR, Russell JA, Walley KR.

Anesthesiology. 2002 Mar;96(3):576-82.

PMID:
11873030
10.

A pilot randomized study comparing high and low volume hemofiltration on vasopressor use in septic shock.

Boussekey N, Chiche A, Faure K, Devos P, Guery B, d'Escrivan T, Georges H, Leroy O.

Intensive Care Med. 2008 Sep;34(9):1646-53. doi: 10.1007/s00134-008-1127-3. Epub 2008 Apr 30.

PMID:
18542921
11.

Continuous terlipressin versus vasopressin infusion in septic shock (TERLIVAP): a randomized, controlled pilot study.

Morelli A, Ertmer C, Rehberg S, Lange M, Orecchioni A, Cecchini V, Bachetoni A, D'Alessandro M, Van Aken H, Pietropaoli P, Westphal M.

Crit Care. 2009;13(4):R130. doi: 10.1186/cc7990. Epub 2009 Aug 10.

12.

Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial.

Lauzier F, Lévy B, Lamarre P, Lesur O.

Intensive Care Med. 2006 Nov;32(11):1782-9. Epub 2006 Sep 22.

PMID:
17019548
13.

Effects of norepinephrine plus dobutamine or norepinephrine alone on left ventricular performance of septic shock patients.

Martin C, Viviand X, Arnaud S, Vialet R, Rougnon T.

Crit Care Med. 1999 Sep;27(9):1708-13.

PMID:
10507587
14.

Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock.

Benchekroune S, Karpati PC, Berton C, Nathan C, Mateo J, Chaara M, Riché F, Laisné MJ, Payen D, Mebazaa A.

J Trauma. 2008 May;64(5):1188-95. doi: 10.1097/TA.0b013e31811f3a45.

PMID:
18469640
15.

Influence of vasopressor agent in septic shock mortality. Results from the Portuguese Community-Acquired Sepsis Study (SACiUCI study).

Póvoa PR, Carneiro AH, Ribeiro OS, Pereira AC; Portuguese Community-Acquired Sepsis Study Group.

Crit Care Med. 2009 Feb;37(2):410-6. doi: 10.1097/CCM.0b013e3181958b1c.

PMID:
19114885
16.

Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.

Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Heyduck M, Stoll C, Peter K.

Crit Care Med. 1999 Apr;27(4):723-32.

PMID:
10321661
17.

Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).

Watson D, Grover R, Anzueto A, Lorente J, Smithies M, Bellomo R, Guntupalli K, Grossman S, Donaldson J, Le Gall JR; Glaxo Wellcome International Septic Shock Study Group.

Crit Care Med. 2004 Jan;32(1):13-20.

PMID:
14707555
18.

The effects of vasopressin on acute kidney injury in septic shock.

Gordon AC, Russell JA, Walley KR, Singer J, Ayers D, Storms MM, Holmes CL, Hébert PC, Cooper DJ, Mehta S, Granton JT, Cook DJ, Presneill JJ.

Intensive Care Med. 2010 Jan;36(1):83-91. doi: 10.1007/s00134-009-1687-x. Epub 2009 Oct 20.

PMID:
19841897
19.

Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock.

Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA 3rd.

Crit Care Med. 2001 Mar;29(3):487-93.

PMID:
11373409
20.

Does body weight impact the efficacy of vasopressin therapy in the management of septic shock?

Miller JT, Welage LS, Kraft MD, Alaniz C.

J Crit Care. 2012 Jun;27(3):289-93. doi: 10.1016/j.jcrc.2011.06.018. Epub 2011 Aug 19.

PMID:
21855282
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk